Department of Family Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
J Clin Endocrinol Metab. 2018 Sep 1;103(9):3310-3318. doi: 10.1210/jc.2018-00408.
Although hypothyroidism is associated with many comorbidities, the evidence for its association with all-cause mortality in older adults is limited.
To evaluate the association between hypothyroidism and all-cause mortality in older adults.
Population-based retrospective cohort study.
National Health Insurance Research Database in Taiwan.
After 1:10 age/sex/index year matching, 2029 patients aged ≥65 years who received a new diagnosis of hypothyroidism between 2001 and 2011 and 20,290 patients without hypothyroidism or other thyroid diseases were included in the hypothyroidism and nonhypothyroidism cohorts, respectively.
All-cause mortality was defined as the primary outcome. Cox proportional hazards regression models were used to calculate the hazard ratios of mortality. To further evaluate the effect of thyroxine replacement therapy (TRT) on mortality, we divided patients with hypothyroidism into two groups: patients who received TRT and those who did not.
Hypothyroidism was associated with an increased risk of all-cause mortality [adjusted hazard ratio (aHR), 1.82; 95% CI, 1.68 to 1.98; P < 0.001]. Patients with hypothyroidism who received TRT had a lower risk of mortality than patients who did not receive TRT (aHR, 0.57; 95% CI, 0.49 to 0.66; P < 0.001). Similar results were obtained after further propensity score matching in age-, sex-, and comorbidity-stratified analyses.
Hypothyroidism was independently associated with increased all-cause mortality in older adults. In patients with hypothyroidism, TRT was associated with a lower risk of all-cause mortality.
尽管甲状腺功能减退症与许多合并症相关,但关于其与老年人全因死亡率之间的关系证据有限。
评估甲状腺功能减退症与老年人全因死亡率之间的关系。
基于人群的回顾性队列研究。
台湾全民健康保险研究数据库。
通过 1:10 年龄/性别/索引年匹配,纳入了 2001 年至 2011 年间新诊断为甲状腺功能减退症的 2029 名年龄≥65 岁的患者和 20290 名无甲状腺功能减退症或其他甲状腺疾病的患者,分别归入甲状腺功能减退症组和非甲状腺功能减退症组。
全因死亡率被定义为主要结局。使用 Cox 比例风险回归模型计算死亡率的风险比。为了进一步评估甲状腺素替代治疗(TRT)对死亡率的影响,我们将甲状腺功能减退症患者分为两组:接受 TRT 的患者和未接受 TRT 的患者。
甲状腺功能减退症与全因死亡率增加相关(调整后的风险比[aHR],1.82;95%置信区间[CI],1.68 至 1.98;P<0.001)。接受 TRT 的甲状腺功能减退症患者的死亡率低于未接受 TRT 的患者(aHR,0.57;95%CI,0.49 至 0.66;P<0.001)。在进一步进行年龄、性别和合并症分层分析的倾向评分匹配后,也得到了类似的结果。
甲状腺功能减退症与老年人全因死亡率增加独立相关。在甲状腺功能减退症患者中,TRT 与全因死亡率降低相关。